Finding a niche for girentuximab in metastatic renal cell carcinoma
A small phase II study highlights modest efficacy and a concerning safety profile associated with this compound in patients with metastatic RCC.06/29/2016
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology